The Asia Pacific Inhaled Nitric Oxide Market would witness market growth of 8.9% CAGR during the forecast period (2020-2026). Inhaled Nitric Oxide is basically a vasodilator that makes precisely selective pulmonary vasodilation. Large number of lab and clinical research studies have been conducted to describe the physiology, biochemistry, side effects, and clinical efficacy of inhaled nitric oxide in many diseases of children and adults.
The usage of inhaled nitric oxide is widely adopted across the world. Inhaled nitric oxide is majorly utilized to cure pulmonary hypertension and hypoxemia in a large number of adults and infants across the world. There are many cases in which inhaled nitric oxide has proved to be the lifesaver of the patient. However, there are many experimental usages of the inhaled nitric oxide which uses a distinct approach to add value benefits to inhaled nitric oxide. Many organizations have conducted studies to find out the ways to cure diseases with the acute rejection of the transplanted lung and sickle cell crisis.
The rising prevalence of diseases in infants like a neonatal hypoxic respiratory failure (HRF) and persistent pulmonary hypertension is among the key driving factors of the market. Moreover, the growing number of patients with chronic obstructive pulmonary disease (COPD), and acute respiratory distress syndrome (ARDS) also propel the market growth. Apart from this, the huge cost involved in the treatment & the stringent government policies on different applications of the gas are restricting the growth of Inhaled Nitric Oxide market. However, the constant R&D activities for discovering various new applications in the healthcare sector are estimated to offer profitable opportunities for expanding the inhaled nitric oxide market during the forecast period.
Based on Application, the market is segmented into Neonatal Respiratory Treatment, Chronic Obstructive Pulmonary Disease (COPD), Acute Respiratory Distress Syndrome (ARDS) and Other Applications. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The China market dominated the Asia Pacific Chronic Obstructive Pulmonary Disease (COPD) Repellent Market by Country in 2019, growing at a CAGR of 7.2 % during the forecast period. The India market is experiencing a CAGR of 10.5% during (2020 - 2026). Additionally, The Japan market is anticipated to grow at a CAGR of 10.6% during (2020 - 2026).
Free Valuable Insights: Inhaled Nitric Oxide Market in Asia Pacific is expected to register a CAGR of 8.9% during the forecast period (2020-2026)
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Getinge AB, Merck Group, Halma PLC, Linde PLC (Praxair, Inc.), Air Liquide S.A., Beyond Air, Inc., Mallinckrodt PLC (International Minerals and Chemical Corporation), VERO Biotech LLC, Nu-Med Plus, Inc. and Novoteris, LLC.
Scope of the Study
Market Segments Covered in the Report:
By Application
- Neonatal Respiratory Treatment
- Chronic Obstructive Pulmonary Disease (COPD)
- Acute Respiratory Distress Syndrome (ARDS)
- Other Applications
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Australia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Getinge AB
- Merck Group
- Halma PLC
- Linde PLC (Praxair, Inc.)
- Air Liquide S.A.
- Beyond Air, Inc.
- Mallinckrodt PLC (International Minerals and Chemical Corporation)
- VERO Biotech LLC
- Nu-Med Plus, Inc.
- Novoteris, LLC
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Inhaled Nitric Oxide Market, by Application
1.4.2 Asia Pacific Inhaled Nitric Oxide Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market composition
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies deployed in Inhaled Nitric Oxide Market – Global
Chapter 4. Asia Pacific Inhaled Nitric Oxide Market by Application
4.1 Asia Pacific Neonatal Respiratory Treatment Repellent Market by Country
4.2 Asia Pacific Chronic Obstructive Pulmonary Disease (COPD) Repellent Market by Country
4.3 Asia Pacific Acute Respiratory Distress Syndrome (ARDS) Market by Country
4.4 Asia Pacific Other Applications Market by Country
Chapter 5. Asia Pacific Inhaled Nitric Oxide Market by Country
5.1 China Inhaled Nitric Oxide Market
5.1.1 China Inhaled Nitric Oxide Market by Application
5.2 India Inhaled Nitric Oxide Market
5.2.1 India Inhaled Nitric Oxide Market by Application
5.3 Japan Inhaled Nitric Oxide Market
5.3.1 Japan Inhaled Nitric Oxide Market by Application
5.4 South Korea Inhaled Nitric Oxide Market
5.4.1 South Korea Inhaled Nitric Oxide Market by Application
5.5 Singapore Inhaled Nitric Oxide Market
5.5.1 Singapore Inhaled Nitric Oxide Market by Application
5.6 Australia Inhaled Nitric Oxide Market
5.6.1 Australia Inhaled Nitric Oxide Market by Application
5.7 Rest of Asia Pacific Inhaled Nitric Oxide Market
5.7.1 Rest of Asia Pacific Inhaled Nitric Oxide Market by Application
Chapter 6. Company Profiles
6.1 Getinge AB
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Regional Analysis
6.1.4 Research & Development Expense
6.2 Merck Group
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.3 Halma PLC
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.4 Linde PLC (Praxair, Inc.)
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Regional Analysis
6.4.4 Research & Development Expense
6.4.5 Recent strategies and developments:
6.4.5.1 Acquisition and Mergers:
6.5 Air Liquide S.A.
6.5.1 Company Overview
6.5.1 Financial Analysis
6.6 Beyond Air, Inc.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Research & Development Expense
6.6.4 Recent strategies and developments:
6.6.4.1 Trials and Approvals:
6.7 Mallinckrodt PLC (International Minerals and Chemical Corporation)
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Segmental and Regional Analysis
6.7.4 Research & Development Expense
6.7.5 Recent strategies and developments:
6.7.5.1 Trials and Approvals:
6.7.5.2 Partnerships, Collaborations, and Agreements:
6.8 VERO Biotech LLC
6.8.1 Company Overview
6.8.2 Recent strategies and developments:
6.8.2.1 Trials and Approvals:
6.9 Nu-Med Plus, Inc.
6.9.1 Company Overview
6.9.2 Recent strategies and developments:
6.9.2.1 Partnerships, Collaborations, and Agreements:
6.10. Novoteris, LLC
6.10.1 Company Overview
6.10.2 Recent strategies and developments:
6.10.2.1 Trials and Approvals:
TABLE 1 Asia Pacific Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
TABLE 2 Asia Pacific Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
TABLE 3 Asia Pacific Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
TABLE 4 Asia Pacific Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
TABLE 5 Asia Pacific Neonatal Respiratory Treatment Repellent Market by Country, 2016 - 2019, USD Million
TABLE 6 Asia Pacific Neonatal Respiratory Treatment Repellent Market by Country, 2020 - 2026, USD Million
TABLE 7 Asia Pacific Chronic Obstructive Pulmonary Disease (COPD) Repellent Market by Country, 2016 - 2019, USD Million
TABLE 8 Asia Pacific Chronic Obstructive Pulmonary Disease (COPD) Repellent Market by Country, 2020 - 2026, USD Million
TABLE 9 Asia Pacific Acute Respiratory Distress Syndrome (ARDS) Market by Country, 2016 - 2019, USD Million
TABLE 10 Asia Pacific Acute Respiratory Distress Syndrome (ARDS) Market by Country, 2020 - 2026, USD Million
TABLE 11 Asia Pacific Other Applications Market by Country, 2016 - 2019, USD Million
TABLE 12 Asia Pacific Other Applications Market by Country, 2020 - 2026, USD Million
TABLE 13 Asia Pacific Inhaled Nitric Oxide Market by Country, 2016 - 2019, USD Million
TABLE 14 Asia Pacific Inhaled Nitric Oxide Market by Country, 2020 - 2026, USD Million
TABLE 15 China Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
TABLE 16 China Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
TABLE 17 China Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
TABLE 18 China Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
TABLE 19 India Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
TABLE 20 India Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
TABLE 21 India Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
TABLE 22 India Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
TABLE 23 Japan Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
TABLE 24 Japan Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
TABLE 25 Japan Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
TABLE 26 Japan Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
TABLE 27 South Korea Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
TABLE 28 South Korea Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
TABLE 29 South Korea Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
TABLE 30 South Korea Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
TABLE 31 Singapore Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
TABLE 32 Singapore Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
TABLE 33 Singapore Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
TABLE 34 Singapore Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
TABLE 35 Australia Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
TABLE 36 Australia Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
TABLE 37 Australia Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
TABLE 38 Australia Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
TABLE 39 Rest of Asia Pacific Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
TABLE 40 Rest of Asia Pacific Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
TABLE 41 Rest of Asia Pacific Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
TABLE 42 Rest of Asia Pacific Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
TABLE 43 Key Information – Getinge AB
TABLE 44 key Information – Merck Group
TABLE 45 key Information – Halma PLC
TABLE 46 key Information – Linde PLC
TABLE 47 Key information – Air Liquide S.A.
TABLE 48 Key information – Beyond Air, Inc.
TABLE 49 Key information – Mallinckrodt PLC
TABLE 50 Key Information – VERO Biotech LLC
TABLE 51 key Information – Nu-Med Plus, Inc.
TABLE 52 key Information –Novoteris, LLC
List of Figures
FIG 1 Methodology for the research